CSF protein ratios with enhanced potential to reflect Alzheimer's disease pathology and neurodegeneration.

Journal Information

Full Title: Mol Neurodegener

Abbreviation: Mol Neurodegener

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Molecular Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateSamples included in the discovery cohort were obtained from the Karolinska University Hospital Medical Unit Aging Memory clinic in Solna, and are part of the GEDOC database and biobank, which was granted general ethical approval (Dnr 2011/1987-31/4). The ethical approval for the current study was received from the Swedish Ethical Review Authority (Dnr 2020-06484). Samples included in the validation cohort were obtained from Amsterdam Dementia Biobank and the respective ethical approval was received from the Amsterdam UMC ethical review board (Approval nr: 2017.315). All participants in both cohorts gave written informed consent for sample and data collection. Consent for publicationNot applicable. Competing interestsThe authors declare no conflict of interest. Competing interests The authors declare no conflict of interest."

Evidence found in paper:

"Funding Open access funding provided by Royal Institute of Technology. This study was funded by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No. 860197 (MIRIADE)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025